SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-014879
Filing Date
2021-04-29
Accepted
2021-04-29 09:17:57
Documents
14
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10022939x1_def14a.htm DEF 14A 948485
2 logo_royaltypharmax1.jpg GRAPHIC 26772
3 nc10022939x1_piecharts01.jpg GRAPHIC 92656
4 nc10022939x1_proxycard01.jpg GRAPHIC 674146
5 nc10022939x1_proxycard02.jpg GRAPHIC 576148
6 royaltypharma-chair.jpg GRAPHIC 4954
7 royaltypharma-expert.jpg GRAPHIC 4862
8 royaltypharma-internet.jpg GRAPHIC 8122
9 royaltypharma-lead.jpg GRAPHIC 5039
10 royaltypharma-mail.jpg GRAPHIC 11398
11 royaltypharma-member.jpg GRAPHIC 5088
12 royaltypharma-phone.jpg GRAPHIC 5845
13 sig_georgelloyd.jpg GRAPHIC 13927
14 sig_pablolegorreta.jpg GRAPHIC 15911
  Complete submission text file 0001140361-21-014879.txt   2937140
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39329 | Film No.: 21867463
SIC: 2834 Pharmaceutical Preparations